Understanding PrEP: The Basics

Pre-Exposure Prophylaxis (PrEP) represents a significant advancement in HIV prevention strategies. PrEP consists of antiretroviral medications—the same type used to treat people living with HIV—but in this case, they're used preventatively by HIV-negative individuals.

Currently, there are two FDA-approved medications for PrEP in the United States:

  • Truvada - A combination of emtricitabine and tenofovir disoproxil fumarate
  • Descovy - Contains emtricitabine and tenofovir alafenamide

Both medications work by creating a protective shield around CD4 cells—the immune cells that HIV targets—preventing the virus from replicating if exposure occurs. When taken consistently, PrEP reduces the risk of getting HIV from sexual contact by about 99% and by at least 74% among people who inject drugs.

It's important to understand that PrEP does not protect against other sexually transmitted infections (STIs) or pregnancy. It specifically targets HIV prevention and works best as part of a comprehensive prevention plan including regular testing for HIV and other STIs.

How PrEP Works in the Body

PrEP medications function as a barrier against HIV infection at the cellular level. When taken daily, these antiretroviral drugs build up in the bloodstream and in the tissues that might be exposed to HIV during sexual activity or injection drug use.

The active ingredients in PrEP medications target specific enzymes that HIV needs to replicate. By blocking these enzymes, PrEP prevents the virus from establishing a permanent infection. Specifically:

  • The medications block an enzyme called HIV reverse transcriptase
  • This prevents HIV from converting its RNA into DNA
  • Without this conversion, HIV cannot integrate into human cells
  • The virus is then unable to make copies of itself and spread

For PrEP to be effective, adequate levels of the medication must be present in the body at the time of exposure. Research shows that it takes about 7 days of daily use for PrEP to reach maximum protection in rectal tissue and about 21 days in vaginal tissue. This is why consistent adherence to the prescribed regimen is critical for PrEP effectiveness.

The body metabolizes PrEP medications over time, which is why daily intake is generally recommended to maintain protective drug levels. However, newer dosing strategies are being studied, including on-demand dosing for specific populations.

Who Should Consider PrEP?

PrEP is not intended for everyone but can be a valuable prevention tool for individuals at substantial risk of HIV infection. Healthcare providers typically recommend PrEP for:

  • Sexually active gay or bisexual men who have had anal sex without a condom or been diagnosed with an STI in the past 6 months
  • Heterosexual men and women who don't regularly use condoms during sex with partners of unknown HIV status who are at substantial risk
  • People who inject drugs and share equipment or have been in drug treatment in the past 6 months
  • Individuals in serodiscordant relationships (where one partner has HIV and the other doesn't)

The decision to start PrEP should involve a detailed conversation with a healthcare provider about risk factors, the commitment to taking medication as prescribed, and regular follow-up appointments. PrEP candidates need to be HIV-negative before starting the medication, as using PrEP when already infected can lead to drug resistance.

Additionally, kidney function must be evaluated before starting PrEP, as these medications can affect kidney health. Other considerations include bone health, pregnancy plans, and potential drug interactions. The ideal candidate for PrEP is someone who can adhere to the medication schedule and attend regular follow-up appointments for HIV testing and monitoring.

Effectiveness and Adherence Factors

The effectiveness of PrEP is directly tied to adherence—taking the medication exactly as prescribed. Clinical trials have shown that when taken consistently, PrEP reduces the risk of HIV infection from sexual contact by approximately 99%. For people who inject drugs, the risk reduction is at least 74%.

However, these impressive statistics depend on proper use. Studies reveal significant differences in effectiveness based on adherence patterns:

  • Taking 7 doses per week provides an estimated 99% protection
  • Taking 4 doses per week provides approximately 96% protection
  • Taking fewer than 4 doses per week significantly reduces protection

Several factors can impact adherence to PrEP. These include side effects (particularly in the first few weeks), stigma associated with taking HIV medication, mental health issues, substance use disorders, housing instability, and lack of access to healthcare. Addressing these barriers through supportive services can improve adherence rates.

Some strategies that help with PrEP adherence include:

  • Setting daily medication reminders on smartphones
  • Using pill organizers to track doses
  • Integrating medication into existing daily routines
  • Joining support groups or working with adherence counselors
  • Addressing underlying issues that might interfere with regular use

Healthcare providers typically monitor PrEP users every three months with HIV tests and screenings for other STIs, providing opportunities to address adherence challenges and adjust support strategies as needed.

Accessing PrEP: Cost and Coverage Options

While PrEP is highly effective, access can be challenging for some individuals due to cost concerns. Without insurance, the retail price for a 30-day supply of PrEP medication can range from $1,600 to $2,000. Fortunately, multiple options exist to make PrEP more affordable:

  • Insurance Coverage: Most private insurance plans, Medicare, and Medicaid cover PrEP medications and the required medical visits and lab tests with minimal or no cost-sharing for the patient.
  • Patient Assistance Programs: Pharmaceutical manufacturers offer programs that provide free medication to eligible individuals who meet income requirements and lack adequate insurance coverage.
  • Ready, Set, PrEP: A national program that provides PrEP at no cost to those who qualify based on income and insurance status.
  • State-specific Programs: Many states have their own PrEP assistance programs that help with medication costs and related medical expenses.
  • Community Health Centers: Federally qualified health centers often provide PrEP services on a sliding fee scale based on ability to pay.

Beyond the cost of medication, accessing PrEP also involves regular healthcare visits. These typically include an initial evaluation, HIV testing, kidney function assessment, screenings for other STIs, and follow-up appointments every three months.

For those facing access barriers, PrEP navigators—healthcare workers who help individuals navigate the healthcare system—can provide invaluable assistance with insurance issues, finding providers, and connecting to financial assistance programs. Many LGBTQ+ community centers, AIDS service organizations, and public health departments offer navigator services.